The RLT Angels Association – A Global Non-Profit for Radioligand Therapy Access

Dedicated to Expanding access. Enhancing care.

RLT Angels Association is a global non-profit initiative dedicated to maximizing patient access to radiotheranostics. We harness world-leading scientific expertise to enable exponential growth of RLT and RLI. The goal is to deliver on the promise of the treatment modality and maximize patient access.

Our mission is to:

1. Improve availability of RLT for 1 million patients globally
2. Enable efficient RLT and RLI delivery through increased capacity across 1000 centers
3. Improve the treatment experience for RLT patients
4. Build a worldwide community of RLT stakeholders

Founding members

Partnerships and collaboration across the healthcare ecosystem are central to the RLT Angels initiative. Our founding members represent a diverse range of industry and non-industry stakeholders, bringing together expertise across clinical, technical, and operational domains. Additionally, founding members will drive meaningful change in order to improve patient acces, experience and outcomes.

RLT Angels Board

RLT Angels is guided by an experienced Board who are responsible for the Association’s strategy and governance.

Prof. Paola Anna Erba

EANM

Dr. Ben Newton

GE HealthCare

Prof. Richard P. Baum

ICPO Foundation

Dr. Zsuzsanna Devecseri

Novartis

Ben Hickey

RayzeBio

The Board are advised by the independent Scientific Advisory Board, and supported by the Management Team.